Pharmaceutical and Healthcare News

14.12.2017

Kazakh pharma companies to be exempt from VAT

The Kazakh Lower Chamber of Parliament has okayed the Senate’s changes in the draft new Tax Code, which provides for exemption from VAT to pharma companies, Kazpravda.kz reports.

On December 7, the Senate returned to Majilis the draft Tax Code and two related bills with their amendments. The changes are: exemption...

The Kazakh Lower Chamber of Parliament has okayed the Senate’s changes in the draft new Tax Code, which provides for exemption from VAT to pharma companies, Kazpravda.kz reports.

On December 7, the Senate returned to Majilis the draft Tax Code and two related bills with their amendments. The changes are: exemption...

13.12.2017

MBionics creates Kazakhstan’s first bionic prosthesis

Maulen Bekturganov, one of Kazakhstan’s 100 New Faces, is the founder of MBionics, the company that developed and created the nation’s first bionic prosthetic hands designed for disabled people of the third group. The young engineer helps people return to regular life after losing a limb.

Fifteen-year-old Akezhan Argyngazin, of the...

Maulen Bekturganov, one of Kazakhstan’s 100 New Faces, is the founder of MBionics, the company that developed and created the nation’s first bionic prosthetic hands designed for disabled people of the third group. The young engineer helps people return to regular life after losing a limb.

Fifteen-year-old Akezhan Argyngazin, of the...

12.12.2017

Oasmia Pharmaceutical receives marketing approval for Paclical® in Kazakhstan

Oasmia Pharmaceutical AB (NASDAQ: OASM), a developer of a new generation of drugs within human and veterinary oncology, announced today that it has received marketing approval for Paclical in Kazakhstan. Paclical is the first water-soluble cancer drug with paclitaxel to receive a market authorization. Paclical will be sold through Hetero...

Oasmia Pharmaceutical AB (NASDAQ: OASM), a developer of a new generation of drugs within human and veterinary oncology, announced today that it has received marketing approval for Paclical in Kazakhstan. Paclical is the first water-soluble cancer drug with paclitaxel to receive a market authorization. Paclical will be sold through Hetero...

31.10.2017

Kazakhstanis start to consume more drugs: domestic producers cannot meet demand

Import substitution on the pharmaceutical market stalls as the import of foreign medicines began to increase again; the share of imports in the domestic market is estimated at 58%.

Importers of medicines are trying to restore their positions in the Kazakhstan market, in January-August this year, Kazakhstan imported 16.6 thousand tonnes...

Import substitution on the pharmaceutical market stalls as the import of foreign medicines began to increase again; the share of imports in the domestic market is estimated at 58%.

Importers of medicines are trying to restore their positions in the Kazakhstan market, in January-August this year, Kazakhstan imported 16.6 thousand tonnes...

30.10.2017

Exit from the crisis and the launch of Public Private Partnership stimulate the growth of investments in health care by 16% on-year

In this year’s first 9 months, investors invested 48 billion tenge in gross capital of the healthcare and social services sector, which is 16.2% more than a year ago. In constant prices the volume of investments increased by 10.8% year-on-year.

The largest proportions of the investments were in Almaty (10.9 billion...

In this year’s first 9 months, investors invested 48 billion tenge in gross capital of the healthcare and social services sector, which is 16.2% more than a year ago. In constant prices the volume of investments increased by 10.8% year-on-year.

The largest proportions of the investments were in Almaty (10.9 billion...


News 1 - 5 of 860
First | Prev. | 1 2 3 4 5 | Next | Last